Diabetic Ketoacidosis and Covid-19: Two Case Reports

Background: covid-19 is a viral infection that causes pneumonia with dyspnea, cough, and fever. its outcomes are more severe in patients with diabetes, hypertension, and other disorders than in healthy people. new-onset diabetes and diabetic ketoacidosis (dka) have been reported as the complications of covid-19 in several studies. it seems that the prevalence of dka due to covid-19 is increasing. therefore, two cases of individuals with dka due to covid-19 are presented in this study to inform other researchers about the details of this phenomenon.material and methods: demographic characteristics, medical histories, physical examinations, laboratory investigations, real-time rt-pcr tests, computed tomography (ct) imaging studies, given treatments, clinical courses, and management outcomes were documented prospectively. results: in the present experience, the manifestation of covid-19 disease in the second case with a history of diabetes was more severe than in the first case. in the second case, with underlying diabetes and covid-19, the dka manifestation was associated with consciousness loss, severe restlessness, and respiratory distress; however, in the first case, with covid-19 without diabetes, the dka manifestation was associated with anorexia, weight loss, and lack of respiratory distress, which were milder symptoms than the second case. conclusion: due to the high prevalence of diabetes mellitus and covid-19 in iran, it is recommended to raise awareness of dka symptoms among health professionals.